Abstract
A homologous series of twenty, hitherto unreported, analogues of 5-halosubstituted 1,3-bis(ω-cyanoalkyl)uracil acyclic nucleosides were synthesized by the series of alkylation reactions of 5-halouracils with the corresponding chloroacetonitrile, chloropropionitrile, chlorobutyronitrile and 5-chlorovaleronitrile (Cl-(CH2)n-CN: n=1, 2, 3, 4) in anhydrous DMSO (or DMF)/K2CO3 (or NaH) under 75°C temperature. Antitumor activities for the synthesized compounds were determined against three cell lines (FM-3A cell, P-388 cell and U-938 cell lines). The compounds that exhibited moderate activity to significant activity, included1a-b, 2a-b, 3a-c, and4a, whose compounds were active against P-388, FM-3A and U-937 cell lines with the compounds1a, 1b, and2a, showing significant antitumor activity (inhibitory concentrations (IC50) ranged from 2.2 to 7.0 μg/ml). Their structure-activity relationship did not show any activity differences in their effective chain length (methyl, ethyl, propyl, butyl) in 1,3-bis(ω-cyanoalkyl) uracils.
Similar content being viewed by others
References cited
Carmichael, j., Degraff, W. G., Gazdar, A. F., Minna, J. D. and Mitchel, J. B., Evaluation of a Tetrazolium based Semiautomated Colorimetric Assay: Assessment of Chemosensitivity Testing.Cancer Res., 47, 936–938 (1987).
Coates, J. A. V., Cammack, N. S., Jenkinson, H. J., Mutton, I. M., Pearson, B. A., Storer, R., Cameron, J. M. and Penn, C. R., The Separated Enantiomers of 2′-Deoxy-3′-Thiacytidine (BCH 189) Both Inhibit Human Immunodeficiency Virus ReplicationIn Vitro Antimicrob.Agents Chemother. 36, 202–205 (1992).
Chu, C. K. and Cutter, S. J., Chemistry and Antiviral Activities of Acyclonucleosides.;J. Hererocycl. Chem., 23, 289–319 (1986).
De Clercq, E. and Walker, R. T., Progress in Medicinal Chemistry; Ellis, G. P., West, G. B., Eds., Elsebvier, New York, 1986; Vol. 23, Chapter 5.
Eliton, G. B., Furman, P. A., Fyfe, J. A., Demiranda, P., Beauchamp, I. and Schaeffer, H. J., Selectivity of Action of an Antiherpetic agent, 9-(2-Hydroxyethoxymethyl)Guanine.Proc. Natl. Acad, Sci., U.S.A., 74, 5716–5720 (1977).
Fisch, M. A., Richman, D. D. and Grieco, M. H., The-Efficacy of Azidothymidine (AZT) in the Treatment of Patient with AIDS and AIDS-Related Complex: a Double-blind, Placebo-Controlled Trial.N. Engl. J. Med., 317, 185–192 (1987).
Kametani, T., Kigasawa, K., Hiiragi, M., Wakisawa, K., Nakazato, K., Ichikawa, K., Fukawa, K., Irino, O., Nishimura, N. and Okada, T., Studies on the Synthesis of Chemotherapeutics. 12. Synthesis and Antitumor Activity of N-phthalidyl-5-Fluorouracil Derivatives.J. Med. Chem., 25, 1219–1222 (1982).
Kelley, J. A., Kelsey, J.E., Hall, W. R., Krochmal, M.P. and Schaeffer, H.J., Pyrimidine Acyclic Nucleosides, 1-[2-(hydroxyethoxy)methyl]pyrimidines as Candidate Antivirals.J. Med Chem., 24, 753 (1981).
Kim, J. C. and Lee, Y. H., Synthesis and Evaluation of Uracil-6-carboxaldehyde Schiff Bases as Potential Antitumor agents. KoreanJ. Med. Chem., 2, 64–67 (1992).
Kim, J. C., Dong, E. S., Kim, J. A., Kim, S. H., Park, J. I. and Kim, S. H., Synthesis and Antitumor Evaluation of Acyclic 5-Substituted Pyrimidine Nucleoside Analogues, KoreaJ. Med. Chem., 4, 111–118 (1994a).
Kim. J.C., Lim, Y.G., Min, B.T. and Park, J.I., Preparation of N′-substituted Anilino-N-Methyl-N′-Nitrosoureas as Candidate Antitumor Agent.Arch. Pharm. Res., 420–423 (1994b).
Kim, J.C., Bae, S. S., Kim, S. H. and Kim, S. H., Synthesis and In Vitro Cytotoxicity of a Homologous Series Of 9-[ω-(N′-methyl-N′-nitrosoureido)alkyl] purine. KoreanJ. Med. Chem., 4, 66–72 (1994c).
Lambert, J. S., Sweglin, M., Reichman, R. C., Plank, C. S. and Dolin, R., 2′, 3′-Dideoxyinosine (DDI) in Patients with Acquired Immunodeficiency Syndrome or AIDS-Related Complex-a Phase I Study.N. Engl. J. Med., 332, 1333–1340 (1990).
Larder, B. A., Darby, G. and Richman, D. D., HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy.Science, 243, 1731–1734 (1989).
Marr, I.I., Berens, R. L., Cohn, N. K., Nelson, D. J. and Klein, R., Biological Action of Inosine Analogs in Leishmania and Trypanosoma spp. Antimicrob.Agents Chemother., 25, 292–295 (1984).
Mitsuya, H., Weinhold, K. J., Furman, P. A., St. Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W. and Broder, S., 3′-Azido-3′-deoxythymidine (BW A509U): Antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type II/lympadenopathy-associated virusin vitro.Proc. Natl. Acad. Sci. 82, 7096–7100 (1985).
Mitsuya, H. and Broder, S., Inhibition of the In vitro Infectivity and Cytopathic Effect of Human T-Lymphotrophic Virus Type III/lymphadenopathy-as-sociated Virus (HTLV-III/LAV) by 2′, 3′-dideoxynucleosides.Proc. Natl. Acad. Sci. U.S.A., 83, 1911–1915 (1986).
Mosmann, T., Rapid Colorimetric Assay for Celluar Growth and Survival: Application to Proliferation and Cytotoxity Assay.J. Immunol. Methods, 65, 55–63 (1983).
Nasr, M., Litterest and McGowan, J., Computer-Assisted Structure Activity Correlations of Dideoxynucleoside Analogs as Potential Anti-HIV Drugs.Antiviral Res. 14, 125–148 (1990).
Norbeck, D. W., spanton, S., Broder, S. and Mitsuya, H., (+)-Dioxolane-T((+)-1-[(2β, 4β)-2(Hydroxymethyl-4-dioxolanyl]-thymine). A New 2′, 3′-Dideoxynucleoside Prototype with in vitro Activity against HIV.Tetrahedron Lett., 30, 6263–6266 (1989).
Schaeffer, H. J., Beauchamp, L., Miranda, P., Elion, G. B., Bauer, D. J. and Collins P., 9-(2-Hydroxyethoxymethyl) guanine Activity Against Viruses of the Herpes Group.Nature, 272, 583–585 (1978).
Schinazi, R. F., Mead, J. F. and Feorino, P. M., Insights into HIV Chemotherapy.AIDS Res. Hum. Retroviruses, 8, 553–579 (1992).
Urbina, J. A., Lazardi, K., Aguirre, M., Piras, M. M. and Piras, R., Antiproliferrative Effects and Mechanism of Action of ICl 195, 739, a novel Bis-triazol Derivative. Antimicrob.Agents Chemother., 35, 730–735 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kim, J.C., Dong, ES., Park, J.I. et al. Synthesis andin vitro cytotoxicity of a homologous series of 5-halosubstituted 1,3-bis(ω-cyanoalkyl)uracil analogues. Arch. Pharm. Res. 19, 62–65 (1996). https://doi.org/10.1007/BF02976822
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02976822